- a relating to the nerves and muscles that cause the blood vessels to constrict or dilate
- Short-term hormone therapy is still the best medical solution for the relief of hot flashes and other so-called vasomotor symptoms.
- If, however, the membranes and sinuses are blanched they are simply water-logged as a result of vasomotor disturbances.
- Loss of energy "without apparent reason"; hot flashes, with or without chilling or sweating; vasomotor (blood vessel) instability, causing occasional dizziness, numbness .
News & Articles
- FDA Approves Non-Hormonal Menopause Tx
The U.S. Food and Drug Administration on July 2nd 2013 issued a release saying the agency has approved the non-hormonal treatment Brisdelle (paroxetine) "to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause".
July 2, 2013 - ThirdAge
- FDA Approves First Non-hormonal Treatment For Menopause Related Hot Flashes
Specialty pharmaceutical company Noven Pharmaceuticals, Inc. announced Friday that the U.S. Food and Drug Administration has approved its Brisdelle (paroxetine) capsules as treatment for moderate to severe hot flashes (vasomotor symptoms) associated with menopause. This is the first and only non-hormonal treatment for moderate to severe hot flashes approved by the FDA.
June 29, 2013 - RTT News
- FDA approves the first non-hormonal treatment for hot flashes associated with menopause
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
June 28, 2013 - U. S. Food and Drug Administration